Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Newport News
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Newport News, VA

Studies commonly pay $75 to $4,500 per completed study

381 clinical trials are currently recruiting participants within 30 miles of Newport News. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

381studies recruiting
4+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Newport News right now

Top 25 of 381 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Peninsula Cancer Institute-Newport News — Newport News, Virginia (9.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospital of The King's Daughters — Norfolk, Virginia (22.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
DaVita Clinical Research Norfolk — Norfolk, Virginia (22.0 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Norfolk, Virginia (22.0 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Norfolk, Virginia (22.0 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Wagner Kapoor Institute — Norfolk, Virginia (22.0 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Norfolk, Virginia (22.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
Virginia Oncology Associates- Norfolk (Brock) /ID# 275227 — Norfolk, Virginia (22.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06890338)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
TPMG Clinical Research — Newport News, Virginia (9.9 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
USO - Virginia Oncology Associates — Norfolk, Virginia (22.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Lymphatic Malformation Phase 2 Interventional 38 participants sought
Children's Hospital of the King's Daughters — Norfolk, Virginia (22.0 mi) · Sponsor: Protara Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT05871970)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10009, Norfolk, VA — Norfolk, Virginia (22.0 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

End Stage Renal Disease, Hemodialysis Access Failure N/A Observational 100 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (22.0 mi) · Sponsor: Merit Medical Systems, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06422871)

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA) Phase 3 Interventional 400 participants sought
Health Res of Hampton Roads — Newport News, Virginia (9.9 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07481630)

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Breast Cancer Phase 2 Interventional 36 participants sought
Virginia Oncology Associates — Norfolk, Virginia (22.0 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05748834)

Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes

Gestational Diabetes Mellitus (GDM) N/A Interventional 110 participants sought
Macon & Joan Brock Virginia Health Sciences at ODU — Norfolk, Virginia (22.0 mi) · Sponsor: Eastern Virginia Medical School
See eligibility & contact on ClinicalTrials.gov (NCT06867861)

The Vanguard Study: Testing a New Way to Screen for Cancer

Bladder Carcinoma, Breast Carcinoma N/A Interventional 24,000 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (22.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06995898)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
York Clinical Research — Norfolk, Virginia (22.0 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07064473)

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Urothelial Cancer Phase 2, Phase 3 Interventional 470 participants sought
Local Institution - 0188 — Norfolk, Virginia (22.0 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07106762)

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer Phase 3 Interventional 192 participants sought
Hampton University Proton Therapy Institute — Hampton, Virginia (10.9 mi) · Sponsor: Proton Collaborative Group
See eligibility & contact on ClinicalTrials.gov (NCT01492972)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Virginia Oncology Associates (VOA) ( Site 8008) — Norfolk, Virginia (22.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Generalized Myasthenia Gravis, gMG Phase 3 Interventional 12 participants sought
Research Site — Norfolk, Virginia (22.0 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06607627)

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Metastatic Hormone-sensitive Prostate Cancer Phase 2 Interventional 150 participants sought
Virginia Oncology Associates — Norfolk, Virginia (22.0 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06991556)
Actively enrolling

Studies you may be able to join near Newport News

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Newport News

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Research of Hampton Roads, Inc.

★ 4.8
720 Thimble Shoals Blvd #110, Newport News, VA 23606
(757) 591-8100
"Very efficient service. Whole process flowed easily. They provide great clinical support. Have done a few studies with them, look forward to doing m…"
— Glenn H, 5★

TPMG Clinical Research - Newport News

860 Omni Blvd Ste 103, Newport News, VA 23606
(757) 232-8836

Velocity Clinical Research

★ 4.0
4000 Coliseum Dr Ste 300, Hampton, VA 23666
(757) 520-5111
"They are the best to ever do it! My experience was informative and good I look forward to participating and helping humanity."
— Tyrone Hyman, 5★

Velocity Clinical Research

★ 5.0
7007 Harbour View Blvd Ste 109, Suffolk, VA 23435
(757) 996-4200
"Staff are very efficient and friendly"
— Katherine Ondrejko, 5★

Clinical trials in Newport News: what's recruiting

The Newport News area currently has 381 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Newport News, the most active research areas are:

  • Cancer & Oncology13 studies
  • Heart & Vascular4 studies
  • Liver & Kidney3 studies
  • Diabetes & Metabolism3 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Newport News, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Newport News

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Newport News participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Newport News safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Newport News?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Newport News?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Newport News.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Newport News typically complete one or two studies per year.

Paid clinical trials near Newport News

Other metros within reach

Norfolk, VA400 Chesapeake, VA401 Virginia Beach, VA400 Richmond, VA608 Fredericksburg, VA33 Alexandria, VA2,289 Arlington, VA2,331 Washington, DC2,362

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Newport News Bladder Issues Due To Spinal Cord Injury in Newport News All conditions

More of VA

Arlington2,331 Alexandria2,289 Richmond608 Chesapeake401 Virginia Beach400 Norfolk400 Roanoke194 Fredericksburg33

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts